Proceedings of the National Academy of Sciences · 2022 · 36 citations · 53 references
Life SciencesGeneticsNeuroscienceAutophagyMolecular NeuroscienceNeurodegenerationAutophagy In DiseaseAutophagy RegulationHuntington DiseaseNeurodegeneration MechanismsNeurodegenerative DiseasesNeurodegenerative DisordersAutophagic VacuolesHuntington Disease AutophagyHuntington Disease Lysosomal DysfunctionHuntington's Disease ModelsNeurological DeteriorationNeurological EtiologyNeuronal VulnerabilityStriatal Degeneration
The CAG expansion of huntingtin (mHTT) associated with Huntington disease (HD) is a ubiquitously expressed gene, yet it prominently damages the striatum and cortex, followed by widespread peripheral defects as the disease progresses. However, the underlying mechanisms of neuronal vulnerability are unclear. Previous studies have shown that SUMO1 (small ubiquitin-like modifier-1) modification of mHtt promotes cellular toxicity, but the in vivo role and functions of SUMO1 in HD pathogenesis are unclear. Here, we report that SUMO1 deletion in Q175DN HD-het knockin mice (HD mice) prevented age-dependent HD-like motor and neurological impairments and suppressed the striatal atrophy and inflammatory response. SUMO1 deletion caused a drastic reduction in soluble mHtt levels and nuclear and extracellular mHtt inclusions while increasing cytoplasmic mHtt inclusions in the striatum of HD mice. SUMO1 deletion promoted autophagic activity, characterized by augmented interactions between mHtt inclusions and a lysosomal marker (LAMP1), increased LC3B- and LAMP1 interaction, and decreased interaction of sequestosome-1 (p62) and LAMP1 in DARPP-32-positive medium spiny neurons in HD mice. Depletion of SUMO1 in an HD cell model also diminished the mHtt levels and enhanced autophagy flux. In addition, the SUMOylation inhibitor ginkgolic acid strongly enhanced autophagy and diminished mHTT levels in human HD fibroblasts. These results indicate that SUMO is a critical therapeutic target in HD and that blocking SUMO may ameliorate HD pathogenesis by regulating autophagy activities.
53
SUMO Modification of Huntingtin and Huntington's Disease Pathology
Joan S. Steffan, Namita Agrawal, Judit Pallos et al. · Science · 2004 · 709 citations · Full text
Allele-selective lowering of mutant HTT protein by HTT–LC3 linker compounds
Zhaoyang Li, Cen Wang, Ziying Wang et al. · Nature · 2019 · 521 citations · Full text